advancing innovation to save lives

A year in review: The global health innovation stories that shaped 2018

Two thousand eighteen was a turbulent year in global health. Between reemerging crises, breakthrough scientific discoveries, and the continued looming threat of health research funding cuts, 2018 took us on a roller coaster ride of peril and promise. As the new year begins, GHTC is taking a moment to look back and reflect on the global health innovation stories and news that shaped 2018.
Learn More

GHTC releases brief analyzing WHO draft roadmap for access

Following the release of the World Health Organization's (WHO) final draft of its Road Map for Access to Medicines, Vaccines and Other Health Products, GHTC has published a new policy brief analyzing the contents of the road map and the potential implications, if approved.
View

Member Spotlight: FHI 360

Long-acting injection shows promise for HIV prevention

Injectable cabotegravir may be an alternative to a daily dose of Truvada® for pre-exposure prophylaxis (PrEP). Learn more

Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We bring together more than 25 nonprofit organizations, academic institutions, and aligned businesses to advance policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity within reach for all people.

Learn more

Flickr/United State Mission Geneva
GHTC issues statement on equitable access to medicines at WHO Executive Board meeting

GHTC issued a statement at the 144th session of the World Health Organization (WHO) Executive Board supporting the ongoing efforts of WHO to increase equitable access to medicines, vaccines, and other health products. The statement, which was issued in partnership with the Global Health Council, the American Academy of Pediatrics, and NCD Child, encourages WHO to support a comprehensive approach to improving access that considers affordability, acceptability, availability, and quality.

PDF

CDC/James Gathany
GHTC responds to RFI on CARB National Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI)on the next National Action Plan for Combatting Antibiotic Resistant Bacteria (CARB) 2020-2025. GHTC’s submission encouraged the prioritization of R&D to combat antimicrobial resistance globally.

PDF
View All News & Events

Member Event

PATH/Gabe Bienczycki
Launch of the 2019 Global Health Briefing Book
Global Health Council
Learn More

Member Event

PATH/Patrick McKern
Empowering Women's Leadership in Global Health R&D
GHIT Fund
Learn More
View All Events
PATH/Felix Masi
Research Roundup: SFOPs funding for FY19, Lassa fever outbreak in West Africa, and new TB drug may shorten treatment time

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Wendy Stone
Research Roundup: New funding partnership to develop drugs for leishmaniasis, an atlas of HIV mutations could improve vaccine design, and a high-tech pill could end drug injections

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide